| Financial Year |
March 31 2023 |
| Monetary Funds |
425,825,460.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
189,473,295.36 |
| Advances to Suppliers |
17,573,687.70 |
| Other Receivables |
1,753,084.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
227,935,812.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
161,970,651.79 |
| Total Current Assets |
1,338,084,725.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,671,764.08 |
| Fixed Assetes |
805,996,474.74 |
| Under-construction Projects |
217,792,223.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
282,202,843.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,919,173.44 |
| Deferred Income Tax Assets |
17,625,998.88 |
| Other Non-Current Assets |
109,594,898.42 |
| Sub-Total of Non-Current Assets |
1,440,406,176.13 |
| Total Assets |
2,778,490,901.35 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,932,500.00 |
| Accounts Payable |
89,619,727.42 |
| Accounts Received In Advance |
1,317,235.96 |
| Employee Compensation Payable |
23,478,130.36 |
| Taxes Payable |
22,195,768.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,166,903.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,579,492.63 |
| Sub-Total of Current Liabilities |
172,430,032.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,271,914.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
53,310,608.15 |
| Total Liabilities |
225,740,640.25 |
| Paid-In Capital(Or Share Stock) |
296,000,000.00 |
| Capital Surplus |
998,902,686.71 |
| Surplus Reserve |
44,472,510.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,017,958,080.27 |
| Minority Stockholder's Interest |
194,874,905.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,357,875,355.88 |
| Owner's Equity（Stockholder's Equity） |
2,552,750,261.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,778,490,901.35 |
